Drug recall · June 22, 2016
Lodrane D recall
Why: Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lodrane D (Brompheniramine maleate 4 mg and Pseudoephedrine HCl 60 mg) Capsules, 60-count bottles, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC 0 00950 86006 8.
- Lots / codes
Lot #'s P0230-022R, P0230-023R, Exp 06/17
- Quantity
- 3827 bottles
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- Nationwide
- Initiated
- May 23, 2016 · Voluntary: Firm initiated
- Classified
- June 15, 2016
- Reported
- June 22, 2016
- Ended
- September 12, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pseudoephedrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.